Life expectancy of early ovarian cancer

The length of life expectancy of patients with early ovarian cancer mainly depends on the patient's own immune tolerance and whether a reasonable and standardized treatment method is chosen during the treatment process. According to clinical data statistics at home and abroad, the five-year survival rate of patients with advanced ovarian cancer is only 30%. It can be seen that effective treatment of ovarian cancer is very important. Choosing an active symptomatic treatment plan can prolong life to a certain extent.

Ovarian cancer develops and spreads to the uterus, appendages or pelvic organs, which is a major problem in both diagnosis and treatment. Developing a scientific and reasonable treatment plan is an important prerequisite for patients to live a long-term survival and improve their quality of life. Surgical resection is currently one of the most effective methods for treating carcinoma in situ, but it is difficult to achieve ideal results for invasive ovarian cancer, especially in the late stage of ovarian cancer, when cancer cells have spread and surgical treatment is less effective. Local therapies such as radiotherapy and chemotherapy are difficult to completely eliminate cancer cells. Patients are prone to relapse after radiotherapy and chemotherapy, and the toxic side effects are large, which can easily damage the patient's various functional organs and is not conducive to the scheduled chemotherapy.

Ovarian cancer is a common and potentially lethal malignant tumor in the female reproductive tract, so many patients and their families are very concerned about how long they can live with advanced ovarian cancer. In fact, the answer from experts is that as long as they actively receive treatment according to the doctor's instructions, they can still prolong their lives.